SCHEMBL19276741

SCHEMBL19276741

CCCCOCC1O[C@@H](OCCC)[C@@H](OC(=O)c2ccccc2)C(OC(=O)c2ccccc2)[C@@H]1O[C@@H]1OC(C(=O)OC)[C@@H](O[C@H]2OC(COCCCC)[C@H](O[C@H]3OC(COCCCC)[C@@H](OC(=O)c4ccccc4)[C@H](OCCCC)C3OCCCC)[C@H](OCCCC)C2OCCCC)C(OC(=O)c2ccccc2)[C@@H]1OC(=O)c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PTPN1 P18031 9/20 0.38
▸ PTPN2 P17706 2/20 0.38
▸ PTPN6 P29350 2/20 0.38
▸ PTPN11 Q06124 2/20 0.38
▸ NT5E P21589 1/20 0.37
▸ FGF2 P09038 3/20 0.36
▸ MDK P21741 1/20 0.36
▸ PAX8 Q06710 1/20 0.36
▸ SSTR1 P30872 1/20 0.35
▸ SSTR2 P30874 1/20 0.35
▸ SSTR4 P31391 1/20 0.35
▸ SSTR3 P32745 1/20 0.35
▸ SSTR5 P35346 1/20 0.35
▸ TACR1 P25103 1/20 0.35
▸ GJB2 P29033 1/20 0.34
▸ ANTXR2 P58335 1/20 0.34
▸ HPSE Q9Y251 3/20 0.34
▸ FGF1 P05230 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19277319 1.00 PTPN1 (0.38) PTPN1PTPN2PTPN6PTPN11NT5E
SCHEMBL19276589 0.94 GJB2 (0.37) PTPN1PTPN2PTPN6PTPN11NT5E
SCHEMBL19276744 0.91 PTPN1 (0.37) PTPN1PTPN2PTPN6PTPN11NT5E
SCHEMBL17087681 0.90 PTPN1 (0.44) PTPN1PTPN2PTPN6PTPN11NT5E
SCHEMBL19276590 0.88 GJB2 (0.38) PTPN1PTPN2PTPN6PTPN11NT5E
SCHEMBL17636477 0.86 FGF2 (0.40) PTPN1PTPN2PTPN6PTPN11NT5E
SCHEMBL17636505 0.86 FGF2 (0.40) PTPN1PTPN2PTPN6PTPN11NT5E
SCHEMBL17636467 0.86 FGF2 (0.40) PTPN1PTPN2PTPN6PTPN11NT5E
SCHEMBL19276735 0.85 SSTR1 (0.48) PTPN1PTPN2PTPN6PTPN11NT5E
SCHEMBL19276742 0.85 SSTR1 (0.48) PTPN1PTPN2PTPN6PTPN11NT5E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170239341-A1 VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE SEROTYPE 8 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2017-08-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170239341-A1 VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE SEROTYPE 8 LGALS8, SIGLEC7, FUT5 PTPN1 1072/4885PTPN2 1305/4885PTPN6 1339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback